Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/30/2007 | CA2651793A1 Hiv fusion inhibitor peptides with improved biological properties |
08/30/2007 | CA2645414A1 Method for screening hiv drug sensitivity |
08/30/2007 | CA2643565A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
08/30/2007 | CA2643200A1 Production of biologically active proteins |
08/30/2007 | CA2642999A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
08/30/2007 | CA2642929A1 Method for producing polyunsaturated fatty acids |
08/30/2007 | CA2642891A1 Strains of lactobacillus helveticuswhich do not ferment lactose |
08/30/2007 | CA2641372A1 Affinity polypeptide for purification of recombinant proteins |
08/30/2007 | CA2638894A1 Plant metabolite exporter gene promoters |
08/30/2007 | CA2638866A1 Peptide based inhibition of capcna protein-protein interactions in cancer |
08/30/2007 | CA2638851A1 Thymic stromal lymphopoietin (tslp) antibodies and uses thereof |
08/30/2007 | CA2638838A1 Ammonia transporter gene and use thereof |
08/30/2007 | CA2638835A1 Gene encoding acetolactate synthase and use thereof |
08/30/2007 | CA2638829A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
08/30/2007 | CA2638780A1 Method of producing chemical product and continuous fermentation apparatus |
08/30/2007 | CA2638762A1 Ammonia transporter gene and use thereof |
08/30/2007 | CA2638122A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
08/30/2007 | CA2638117A1 Generation of heavy-chain only antibodies in transgenic animals |
08/30/2007 | CA2637588A1 Chimeric regulatory sequences comprising introns from dicotyledons for plant gene expression |
08/30/2007 | CA2637271A1 Selection of host cells expressing protein at high levels |
08/30/2007 | CA2636449A1 Vascular tumor markers |
08/30/2007 | CA2635472A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases |
08/30/2007 | CA2630218A1 Viral gene products and methods for vaccination to prevent viral associated diseases |
08/30/2007 | CA2604276A1 Gene encoding protein with vicinal diketone or diacetyl-reducing activity and use thereof |
08/29/2007 | EP1826569A1 Identifying material from a breast duct |
08/29/2007 | EP1826561A1 A substrate, a method for quantification of a target substance |
08/29/2007 | EP1826560A2 Methods for introducing heterologous cells into fish |
08/29/2007 | EP1826273A1 Method for the production of a strain having a deleted region in chromosome |
08/29/2007 | EP1826272A2 Genes |
08/29/2007 | EP1826271A2 Thermophilic fungal expression system |
08/29/2007 | EP1826270A1 Method and library for in vitro selection |
08/29/2007 | EP1826269A1 Method of detecting h5 or h7 avian influenza virus |
08/29/2007 | EP1826268A1 Ccr6- deficient mice or cells and modulation of inflammatory diseases |
08/29/2007 | EP1826267A1 Novel halogenases |
08/29/2007 | EP1826265A2 Materials and methods for the modification of plant lignin content |
08/29/2007 | EP1826218A1 Antihuman baff antibody |
08/29/2007 | EP1826215A2 Method of obtaining the expression or improving the rate of expression of a gene |
08/29/2007 | EP1825863A1 Recombinant porcine adenovirus vector |
08/29/2007 | EP1825859A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
08/29/2007 | EP1824998A1 Method for directing nucleic acids to plastids |
08/29/2007 | EP1824984A2 In-vitro method for producing oocytes or eggs having targeted genomic modification |
08/29/2007 | EP1824983A2 Oxygen-controlled environment for cell- and tissue culture |
08/29/2007 | EP1824982A2 Methods of increasing seed yield |
08/29/2007 | EP1824981A2 Novel mutation involved in increased tolerance to imidazolinone herbicides in plants |
08/29/2007 | EP1824980A2 Rhamnose promoter expression system |
08/29/2007 | EP1824979A2 Methods, products and uses involving platelets and/or the vasculature |
08/29/2007 | EP1824978A1 Hcv f protein and uses thereof |
08/29/2007 | EP1824977A1 Novel promoter nucleic acid derived from corynebacterium genus bacteria, expression cassette comprising the promoter and vector comprising the cassette, host cell comprising the vector and method for expressing a gene using the cell |
08/29/2007 | EP1824976A1 Antimicrobial peptides |
08/29/2007 | EP1824975A2 Lna oligonucleotides and the treatment of cancer |
08/29/2007 | EP1824970A2 Trichoderma reesei glucoamylase and homologs thereof |
08/29/2007 | EP1824969A1 Improved mevalonate kinase |
08/29/2007 | EP1824967A2 Recombinant dna constructs and methods for controlling gene expression |
08/29/2007 | EP1824878A1 Tnf antagonists |
08/29/2007 | EP1824875A1 Plant proteins having an abscisic acid binding site and methods of use |
08/29/2007 | EP1824872A2 Rnai modulation of mll-af4 and uses thereof |
08/29/2007 | EP1824519A2 Inhibition of li expression in mammalian cells |
08/29/2007 | EP1824517A2 Methods of treatment using melanopsin |
08/29/2007 | EP1824512A2 Improved dna immunization with recombinase/transposase |
08/29/2007 | EP1824510A2 Use of flagellin in the immunotherapy of yersinia pestis |
08/29/2007 | EP1824498A2 Methods and compositions for treating cellular proliferative diseases |
08/29/2007 | EP1670903B1 Treatment of neurodegenerative diseases |
08/29/2007 | EP1636845A4 Wet chemical processing chambers for processing microfeature workpieces |
08/29/2007 | EP1631685A4 Nucleic acid processing methods, kits and devices |
08/29/2007 | EP1562417A4 Benzoate inducible promoters |
08/29/2007 | EP1549754B1 Feedback-resistant homoserine transsuccinylases |
08/29/2007 | EP1517913B9 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
08/29/2007 | EP1511376A4 Transgenic zebrafish models for thrombosis |
08/29/2007 | EP1485471B1 Alcohol dehydrogenases with high solvent and temperature stability |
08/29/2007 | EP1463816B1 Method for controlled induction of somatic mutations and use thereof in proteomics |
08/29/2007 | EP1450847A4 Apo2 ligand/trail formulations |
08/29/2007 | EP1449913B1 Gamma-glutamylcysteine-producing yeast |
08/29/2007 | EP1414961B1 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
08/29/2007 | EP1414958B1 Method for gene expression |
08/29/2007 | EP1377156A4 Method of enhancing entomophilous |
08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
08/29/2007 | EP1292710B1 Matrix screening method |
08/29/2007 | EP1242442B1 Process for the scaleable purification of plasmid dna |
08/29/2007 | EP1165781B1 Protease resistant flint analogs |
08/29/2007 | EP1163844B1 Transgenic mollusc and method for constructing the same |
08/29/2007 | EP1140997B1 Chlamydia trachomatis antigens |
08/29/2007 | EP1140024B1 Particles for oral delivery of peptides and proteins |
08/29/2007 | EP1067189B1 Gene encoding flavone synthase |
08/29/2007 | EP1056875B1 Synthetic promoters |
08/29/2007 | EP1054963B1 Sequences of an ih ionic channel and the use thereof |
08/29/2007 | EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
08/29/2007 | EP1032269B1 Treatment of neoplasms with interferon-sensitive, clonal viruses |
08/29/2007 | EP1015562B1 Modification of polysaccharides |
08/29/2007 | EP1009814B1 Human receptor tyrosine kinase, kdr |
08/29/2007 | EP1007653B1 Detection methods comprising the use of polypeptides comprising a coiled-coil and an addition site |
08/29/2007 | EP0998585B1 Screening methods using an atpase protein from a virus of the flaviviridae family |
08/29/2007 | EP0975755B9 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
08/29/2007 | EP0953644B1 Systems for the mass production of proteins or peptides by microorganisms of the genus humicola |
08/29/2007 | EP0953039B1 Animal models of human prostate cancer progression |
08/29/2007 | EP0935657B1 Modified steroid hormone receptors |
08/29/2007 | EP0910635B1 Hematopoietic cytokine receptor |
08/29/2007 | EP0763059B1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
08/29/2007 | EP0736605B2 Process for producing proteins |
08/29/2007 | CN101027407A Method for detecting base mutation |
08/29/2007 | CN101027400A A method to increase pathogen resistance in plants |